PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 169.0
(0.59%)
IDR 169.0
(0.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 40.75 Billion IDR | 406.08% |
| 2022 | -13.31 Billion IDR | 65.21% |
| 2021 | -38.27 Billion IDR | -168.41% |
| 2020 | -14.26 Billion IDR | -780.45% |
| 2019 | 2.09 Billion IDR | -43.15% |
| 2018 | 3.68 Billion IDR | 409.62% |
| 2017 | -1.19 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 52.75 Billion IDR | 4.26% |
| 2024 Q1 | 50.59 Billion IDR | 8.77% |
| 2023 Q1 | 3.68 Billion IDR | 127.64% |
| 2023 Q2 | 11.18 Billion IDR | 203.9% |
| 2023 FY | 46.51 Billion IDR | 449.33% |
| 2023 Q4 | 46.51 Billion IDR | 150.81% |
| 2023 Q3 | 18.54 Billion IDR | 65.79% |
| 2022 FY | -13.31 Billion IDR | 65.21% |
| 2022 Q4 | -13.31 Billion IDR | 29.36% |
| 2022 Q3 | -18.85 Billion IDR | 12.34% |
| 2022 Q2 | -21.5 Billion IDR | 55.14% |
| 2022 Q1 | -47.94 Billion IDR | -25.24% |
| 2021 Q1 | -61.65 Billion IDR | -322.69% |
| 2021 FY | -38.27 Billion IDR | -168.41% |
| 2021 Q3 | -31.87 Billion IDR | 36.7% |
| 2021 Q4 | -38.27 Billion IDR | -20.1% |
| 2021 Q2 | -50.34 Billion IDR | 18.34% |
| 2020 Q1 | 1.39 Billion IDR | 17.02% |
| 2020 FY | -14.26 Billion IDR | -780.45% |
| 2020 Q4 | -14.58 Billion IDR | 0.0% |
| 2020 Q2 | -9.52 Billion IDR | -783.73% |
| 2019 Q4 | 1.19 Billion IDR | 0.0% |
| 2019 FY | 2.09 Billion IDR | -43.15% |
| 2019 Q3 | 1.19 Billion IDR | 0.0% |
| 2018 FY | 3.68 Billion IDR | 409.62% |
| 2017 FY | -1.19 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Prodia Widyahusada Tbk | -511.59 Billion IDR | 107.967% |